Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin : the development of a prediction model .
patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer